Research on Pulmonary Hypertension Discussed by Researchers at Complutense University Madrid (Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the ...)

Media coverage

• Title	Research on Pulmonary Hypertension Discussed by Researchers at Complutense University Madrid (Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the ...)
  Media name/outlet	NewsRx Hematology Daily
  Date	6/04/23
  Persons	Luis Oswaldo Izquierdo Villavicencio